Susan Bal

@bhemato @uabmedicine @MedicalCollege Thank you so much for the invitation. It was a lovely visit

⁦@SusanBal9⁩ giving an excellent talk on myeloma immunotherapy - Controversies in Heme Malignancies; Milwaukee ⁦@uabmedicine⁩ ⁦@MedicalCollege⁩

I'm running with MMRF Team for Cures to fundraise for the Multiple Myeloma Research Foundation. With each mile, I hope to accelerate the discovery of cures for the second most common blood cancer. Will you help me reach my fundraising goal? do.nr/swmnku18 via @DonorDrive

@rajshekharucms @awechalekar @SLentzsch @VincentRK Totally agree, these patients are so challenging. We still err on side of caution and continue IVIG q-month primary prophylaxis with anti microbials if recurrent infections

Patients with heavy proteinuria are challenging. I use IVIG 400 mg/kg q-monthly for primary prophylaxis, but still struggle to keep trough level >400 mg/dL. Have also seen some cases of bronchiectasis due to recurrent low grade respiratory infections in the setting of hypogammaglobulinemia in these patients.

The Achilles heel of BCMA BsAb management outside of high-volume myeloma centers is not CRS/ICANS but adequate infection prophylaxis, meticulous surveillance for early signs of infection, and prompt management (akin to allo-transplant recipients)! While prophylactic Toci and outpatient administration are all good for convenience and logistics, the latter is going to be most impactful for safe delivery of these drugs in the community! #mmsm

@End_myeloma @RahulBanerjeeMD @JoshuaRichterMD 🤣😂

@RahulBanerjeeMD @JoshuaRichterMD Who is Drake?

MM docs in US pulse check. what is in a name...

@OncLive @szusmani Congratulations!

Big smiles during this celebratory night at Giants of Cancer Care. A heartfelt congratulations to @szusmani! #GiantsCC25

@AlGarfall @End_myeloma 🙏🏼🙏🏼

Very nice study by @SusanBal9 & @End_myeloma demonstrating marked reduction in MRD burden after auto SCT in patients receiving quad induction for myeloma #mmsm rdcu.be/ejHBb

Thank you for the invitation @szusmani and Sham Mailankody to join this fantastic meeting, really great presentations and discussion.

The funnest talk from @JoshuaRichterMD and a new acronym for neurotoxicity with gprc5d #iwgprc5d2025

Practical tips from @RahulBanerjeeMD #iwgprc5d2025 on managing skin and nail toxicities

Thank you for sharing and thanks to @TheLancetHaem for the opportunity to pen this commentary on an important update of a major practice informing - monumental study

@FinlaysonMac @MM_Hub @UABDeptMed I completely agree that it’s always disappointing when it happens. But unfortunately when we design a phase 1 study and we are not aware of the safety profile of the agent, the sponsor errs on side of caution. I hope your wife is able to join the study in the future.

@MM_Hub @SusanBal9 @UABDeptMed I hoped my wife could get this drug upon DP after 18 mos on tec. She was excluded from the trial due to PCL @ dx in 2018, never since, and due to being oligosecretory. Couldn’t there be a second arm for such patients? Please do better for the patients w/ the greatest need.

CONGRESS | #ASH24 | POSTER | Susan Bal @SusanBal9 @UABDeptMed presents the updated phase I safety and efficacy results for BMS-986393 for RRMM with 1–3 prior regimens. Single dose BMS-986393 at the RP2D demonstrated and ORR rate of 96% with deepening responses over time. No new safety signals observed, supporting further investigation as a treatment for early relapsed disease. Follow our live feed for more updates: loom.ly/o2oK2qI #mmsm #myeloma #MedicalCongress

@MyelomaTeacher @HealthTree Thank you for having me!

@SusanBal9 Thanks for stopping by after a long day to provide the @HealthTree patient audience an update too!

@JoshuaRichterMD Glad to have a friend in this scary backstage 😳😳😳

Watching ⁦@SusanBal9⁩ crush it at #ASH24 with the updated data on Arlo-cel. The GPRC5d CART. #mmsm

@SurbhiSidanaMD @VincentRK @thanosdimop Thanks @SurbhiSidanaMD, encouraging results in this space, we will be updating the PFS and OS data on Monday (slightly different)

@VincentRK @thanosdimop ash.confex.com/ash/2024/webpr… @SusanBal9 #ASH24 #mmsm GPRC5D CAR-T in RRMM ORR 84% ORR 79% in prior BCMA treated patients ORR 86% in EMD! Median PFS 14.5 months AE: Ataxia of 7% Addresses high unmet need

6 AM flight to #ASH24 #ASHFriday for 8:30 AM meeting start! Excited to see friends and colleagues and hear amazing science Top 3 #mmsm abstracts I am looking forward to 1. Anito-cel in MM 2. AQUILA - daratumumab in smoldering MM 3. GPRC5D CAR-T in MM Links 👇

@mdbrunocosta @VincentRK @MDAndersonNews Congrats @mdbrunocosta

@VincentRK @MDAndersonNews Thank you so much, Dr. Rajkumar! It’s an honor to learn from leaders like you, and I aim to follow your example in advancing the field

One of the happiest moments of my life: matched into my #1 choice for Hem/Onc fellowship—@MDAndersonNews, here we go! I am grateful beyond words to every single person who supported, taught, inspired, and believed in me along this journey, and I promise to make the most of this opportunity to positively impact care for patients with cancer.

We showed identical MRD responses as Quadruplet+ASCT and were able to spare a quarter of patients the toxicity of ASCT. Important to follow long term outcomes but so far so good! Larger studies Master-2 and MIDAS if further answer this and other important qs. But it can be done!

At #IMS2024 we shared the first results from a pilot study of real time MRD-adapted deferral of ASCT in #mmsm absolutely could not have done this without the support of @End_myeloma and our fantastic MM team @uabmedicine

@SLentzsch @DrKrinaPatel @MDAndersonNews @SagarLonialMD @ninashah33 @thanosdimop Fantastic, congratulations @DrKrinaPatel so well deserved

#SOHO2024 Celebrating @DrKrinaPatel in her new role as Myeloma Section Chief at @MDAndersonNews Congratulations 🎊 @SagarLonialMD @ninashah33 @thanosdimop

@rajshekharucms @columbiacancer Congratulations, Raj!

Teaching is one of the most rewarding parts of my job, and such an honor to receive this award from our fellows ⁦@columbiacancer⁩!

@szusmani @richaparikh36 @cricketworldcup @sridevirajeeve @hhashmi87 Wow, awesome you guys got to experience this in real time 😊👍

Let’s go #cocacolacricket @cricketworldcup 🇵🇰🇮🇳🏏 MSK MYL Team representing